BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium

Stock Information for Biolargo Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biolargo Inc

BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution
BioLargo Installs AEC PFAS Treatment System at Lake Stockholm, New Jersey
BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST
BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation
BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS Breakthrough
BioLargo to Present at NobleCon's 21st Annual Emerging Growth Equity Conference, Dec. 2-3, 2025
BioLargo Reports Q3 2025 Operating and Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.